These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29684141)

  • 61. Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study.
    Porter DP; Daeumer M; Thielen A; Chang S; Martin R; Cohen C; Miller MD; White KL
    Viruses; 2015 Dec; 7(12):6360-70. PubMed ID: 26690199
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Optimizing Antiretroviral Therapy in Heavily ART-Experienced Patients with Multi-Class Resistant HIV-1 Using Proviral DNA Genotypic Resistance Testing.
    Rauschning D; Ehren I; Heger E; Knops E; Fätkenheuer G; Suárez I; Lehmann C
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515133
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics.
    Kühnert D; Kouyos R; Shirreff G; Pečerska J; Scherrer AU; Böni J; Yerly S; Klimkait T; Aubert V; Günthard HF; Stadler T; Bonhoeffer S;
    PLoS Pathog; 2018 Feb; 14(2):e1006895. PubMed ID: 29462208
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
    Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
    PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HIV drug resistance mutations in proviral DNA from a community treatment program.
    Derache A; Shin HS; Balamane M; White E; Israelski D; Klausner JD; Freeman AH; Katzenstein D
    PLoS One; 2015; 10(1):e0117430. PubMed ID: 25635815
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessment of Transmitted HIV-1 Drug Resistance Mutations Using Ultra- Deep Pyrosequencing in a Turkish Cohort.
    Sili U; Aksu B; Tekin A; Hasdemir U; Soyletir G; Korten V
    Curr HIV Res; 2018; 16(3):216-221. PubMed ID: 30198436
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drug resistance is rarely the cause or consequence of long-term persistent low-level viraemia in HIV-1-infected patients on ART.
    Vancoillie L; Mortier V; Demecheleer E; Schauvliege M; Vandekerckhove L; Vogelaers D; Verhofstede C
    Antivir Ther; 2015; 20(8):789-94. PubMed ID: 25945956
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption.
    Darwich L; Esteve A; Ruiz L; Bellido R; Clotet B; Martinez-Picado J
    Antivir Ther; 2008; 13(7):945-51. PubMed ID: 19043929
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.
    Violin M; Forbici F; Cozzi-Lepri A; Velleca R; Bertoli A; Riva C; Giannella S; Manconi PE; Lazzarin A; Pasquinucci S; Tacconi L; Carnevale G; Mazzotta F; Bonazzi L; Montroni M; Chirianni A; Capobianchi M; Ippolito G; Moroni M; Perno CF; D'Arminio-Monforte A;
    J Biol Regul Homeost Agents; 2002; 16(1):37-43. PubMed ID: 12003172
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.
    Gonsalez CR; Alcalde R; Nishiya A; Barreto CC; Silva FE; de Almeida A; Mendonça M; Ferreira F; Fernandes SS; Casseb J; Duarte AJ
    Virus Res; 2007 Nov; 129(2):87-90. PubMed ID: 17686543
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
    Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
    J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.
    Aleman S; Söderbärg K; Visco-Comandini U; Sitbon G; Sönnerborg A
    AIDS; 2002 May; 16(7):1039-44. PubMed ID: 11953470
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis of a long-term discrepancy in drug-targeted genes in plasma HIV-1 RNA and PBMC HIV-1 DNA in the same patient.
    Usuku S; Noguchi Y; Sakamoto M; Adachi T; Sagara H; Sudo K; Nishizawa M; Kondo M; Tochikubo O; Imai M
    Jpn J Infect Dis; 2006 Apr; 59(2):122-5. PubMed ID: 16632914
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.
    Capiluppi B; Saracco A; Gianotti N; Mussini C; Butini L; Tomasoni L; De Gennaro M; Rizzolo L; Monolo G; Cargnel A; Moioli C; Arici C; Portelli V; Rizzardini G; Lazzarin A; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):73-8. PubMed ID: 12003179
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.
    Vergne L; Kane CT; Laurent C; Diakhaté N; Gueye NF; Gueye PM; Sow PS; Faye MA; Liégeois F; Ndir A; Lanièce I; Peeters M; Ndoye I; Mboup S; Delaporte E
    AIDS; 2003 Jul; 17 Suppl 3():S31-8. PubMed ID: 14565607
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes.
    de Mendoza C; Rodriguez C; Corral A; del Romero J; Gallego O; Soriano V
    Clin Infect Dis; 2004 Oct; 39(8):1231-8. PubMed ID: 15486849
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
    Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
    J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy.
    Alves BM; Siqueira JD; Garrido MM; Botelho OM; Prellwitz IM; Ribeiro SR; Soares EA; Soares MA
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29257103
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The relevance of ultradeep sequencing for low HIV-1 viral loads and proviruses in the clinical setting.
    Foury A; Saunier A; Taverniers A; Pinet N; Josse T; Jeanmaire E; Emilie C; Schvoerer E; Hartard C
    J Med Virol; 2024 Aug; 96(8):e29870. PubMed ID: 39185639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.